The cerebral biochemistry associated with the development of many neurological diseases
remains poorly understood. In particular, incomplete understanding of the mechanisms
through which vascular inflammation manifests in tissue damage and altered brain function
is a significant hindrance to the development of improved patient therapies. To this extent, a
combination of spectrometric/spectroscopic mapping/imaging methods with an inherent
ability to provide a wealth of biochemical and physical information have been investigated to …